Results 21 to 30 of about 21,592 (215)

Substrate antagonism in the kinetic mechanism of E. coli phosphofructokinase‐1 [PDF]

open access: bronzeFEBS Letters, 1991
In the presence of its allosteric activator GDP, the major phosphofructokinase‐1 from Escherichia coli K12 follows Michaelis—Menten kinetics. The kinetic behavior observed at steady‐state using different concentrations of the substrates ATP and fructose‐6‐phosphate and the pattern of inhibition by the substrate analogs adenylyl‐(β,γ‐methylene ...
Dominique Deville‐Bonne   +2 more
openalex   +3 more sources

Wnt signaling promotes tumor development in part through phosphofructokinase 1 platelet isoform upregulation

open access: bronzeOncology Reports, 2021
The activation of Wnt signaling has been detected in various types of human cancer and has been shown to be associated with cancer development. In the present study, it was revealed that Wnt signaling induced the expression of phosphofructokinase 1 platelet isoform (PFKP), which has been reported to catalyze a rate‑limiting reaction in glycolysis and ...
So Mi Jeon, Je Lim, Su Park, Jong-Ho Lee
openalex   +4 more sources

Filament Assembly by Phosphofructokinase-1, the Gatekeeper of Glycolysis [PDF]

open access: bronzeBiophysical Journal, 2014
The cytoskeleton is conventionally viewed as being composed of three filamentous networks; microfilaments, microtubules, and intermediate filaments. This view is challenged by the findings that metabolic enzymes can form filaments with structural functions.
Bradley A. Webb   +2 more
openalex   +4 more sources

PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP [PDF]

open access: yesBiomarker Research
Lung cancer is the leading cause of cancer-related deaths worldwide, with lung squamous cell carcinoma (LUSC) lacking effective targeted therapies. Recent studies have identified Plakophilin-1 (PKP1) as one of the most differentially overexpressed genes ...
Félix Ritoré-Salazar   +8 more
doaj   +2 more sources

Phenolic acids from Anisopus mannii modulates phosphofructokinase 1 to improve glycemic control in patients with type 2 diabetes: A double-blind, randomized, clinical trial

open access: goldPharmacological Research
Phenolic acid-rich fraction from Anisopus mannii (PhAM) contains abundance of ferulic acid, gallic acid, protocatechuic acid, and syringic acid.
Peter U. Amadi   +13 more
doaj   +2 more sources

Interaction of murine monoclonal subunit‐specific antibodies with phosphofructokinase‐1 from Saccharomyces cerevisiae [PDF]

open access: bronzeFEBS Letters, 1995
Murine monoclonal subunit‐specific antibodies against heterooctameric phosphofructokinase‐1 from Saccharomyces cerevisiae exhibiting no cross‐reactivity were purified and characterized regarding complex formation with the native enzyme, immunological reactivity to the SDS‐denatured subunits originating from native and proteolytically truncated ...
Gèrhard Kopperschläger   +2 more
openalex   +3 more sources

Reversible High Affinity Inhibition of Phosphofructokinase-1 by Acyl-CoA [PDF]

open access: hybridJournal of Biological Chemistry, 2011
Christopher M. Jenkins   +3 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy